Cencora’s current market performance is reflected in its price of $296.23 USD, which has experienced significant growth and volatility over the past year.
Cencora Inc’s stock value has more than doubled over the past three years, resulting in a significant increase in market capitalization to over $55 billion.
Cencora Inc has seen a significant surge in its stock price, with a 100% return on investment for those who bought in 2022, driving its market capitalization to over $55 billion.
Cencora Inc. has appointed Lori J. Ryerkerk to its board of directors, a strategic move expected to drive growth and expansion in the pharmaceutical industry.